NO20000098L - Anvendelse av hyaluronidase ved fremstillingen av et medikament for behandling av inflammasjon - Google Patents

Anvendelse av hyaluronidase ved fremstillingen av et medikament for behandling av inflammasjon

Info

Publication number
NO20000098L
NO20000098L NO20000098A NO20000098A NO20000098L NO 20000098 L NO20000098 L NO 20000098L NO 20000098 A NO20000098 A NO 20000098A NO 20000098 A NO20000098 A NO 20000098A NO 20000098 L NO20000098 L NO 20000098L
Authority
NO
Norway
Prior art keywords
hyaluronidase
treatment
inflammation
medicament
manufacture
Prior art date
Application number
NO20000098A
Other languages
English (en)
Other versions
NO20000098D0 (no
Inventor
Cecilia Johnsson
Gunnar Tufveson
Roger Hollgren
Bengt Gerdin
Original Assignee
Cecilia Johnsson
Gunnar Tufveson
Roger Hollgren
Bengt Gerdin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cecilia Johnsson, Gunnar Tufveson, Roger Hollgren, Bengt Gerdin filed Critical Cecilia Johnsson
Publication of NO20000098D0 publication Critical patent/NO20000098D0/no
Publication of NO20000098L publication Critical patent/NO20000098L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20000098A 1997-07-09 2000-01-07 Anvendelse av hyaluronidase ved fremstillingen av et medikament for behandling av inflammasjon NO20000098L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702657A SE512633C2 (sv) 1997-07-09 1997-07-09 Användning av hyaluronidas för reduktion av inflammatoriska cellinfiltrat
PCT/SE1998/000831 WO1999002181A1 (en) 1997-07-09 1998-05-06 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation

Publications (2)

Publication Number Publication Date
NO20000098D0 NO20000098D0 (no) 2000-01-07
NO20000098L true NO20000098L (no) 2000-01-07

Family

ID=20407703

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000098A NO20000098L (no) 1997-07-09 2000-01-07 Anvendelse av hyaluronidase ved fremstillingen av et medikament for behandling av inflammasjon

Country Status (11)

Country Link
US (1) US6572855B1 (no)
EP (1) EP0994719B1 (no)
JP (1) JP2002509542A (no)
AT (1) ATE332706T1 (no)
AU (1) AU741770B2 (no)
CA (1) CA2296581A1 (no)
DE (1) DE69835210T2 (no)
ES (1) ES2267186T3 (no)
NO (1) NO20000098L (no)
SE (1) SE512633C2 (no)
WO (1) WO1999002181A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026666A1 (de) * 2000-05-29 2001-12-20 Gunther Burgard Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen
US6682904B1 (en) * 2002-08-15 2004-01-27 Deliatroph Pharmaceuticals, Inc. Specific inhibitors of hyaluronidase 2, and methods of identifying and using same
JP4464395B2 (ja) 2003-03-05 2010-05-19 ヘイローザイム インコーポレイテッド 可溶性ヒアルロニダーゼ糖タンパク質（ｓＨＡＳＥＧＰ）、その調製プロセス、使用およびそれを含む薬学的組成物
WO2008149428A1 (ja) * 2007-06-05 2008-12-11 Glycoscience Laboratories, Inc. 自己免疫疾患、炎症及び神経疾患の治療剤及び予防剤
EP2285402A2 (en) 2008-04-14 2011-02-23 Halozyme, Inc. Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
US8784896B2 (en) 2012-09-17 2014-07-22 Biopep Solutions, Inc Antioxidant therapy with a whole, leech saliva extract

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8504025D0 (en) * 1985-02-16 1985-03-20 Biopharm Ltd Hyaluronidase
US5747027A (en) * 1995-04-07 1998-05-05 The Regents Of The University Of California BH55 hyaluronidase
US5958750A (en) 1996-07-03 1999-09-28 Inctye Pharmaceuticals, Inc. Human hyaluronidase

Also Published As

Publication number Publication date
ATE332706T1 (de) 2006-08-15
SE512633C2 (sv) 2000-04-17
EP0994719B1 (en) 2006-07-12
EP0994719A1 (en) 2000-04-26
JP2002509542A (ja) 2002-03-26
NO20000098D0 (no) 2000-01-07
SE9702657L (sv) 1999-01-10
AU741770B2 (en) 2001-12-06
DE69835210T2 (de) 2007-07-05
SE9702657D0 (sv) 1997-07-09
AU7461898A (en) 1999-02-08
CA2296581A1 (en) 1999-01-21
ES2267186T3 (es) 2007-03-01
WO1999002181A1 (en) 1999-01-21
US6572855B1 (en) 2003-06-03
DE69835210D1 (de) 2006-08-24

Similar Documents

Publication Publication Date Title
TR200100189T2 (tr) Hücre yapışması engelleyici iltihaplanmaya karşı bileşikler
CA2105529A1 (en) Composition comprising non-steroidal anti-inflammatory agent and effectively non-antibacterial tetracycline
TR200200160T2 (tr) Antiinflamatuar ajanlar olarak imidazoller ve triazoller
WO2000027381A3 (en) Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
AR009560A1 (es) Prolongacion de la sobrevida de injertos con porfirinas
GB9807639D0 (en) Anti-inflammatory agents
PT1131039E (pt) Utilizacao de uma substancia que se liga ao receptor periferico das benzodiazepinas no tratamento de stresses cutaneos
ATE448797T1 (de) Zusammensetzung enthaltend il-1ra als interleukin-1 inhibitor und hyaluronan als polymer mit verzögerter wirkstofffreigabe
SE9800806L (sv) Användning av kollagenas
DK0813417T3 (da) Anvendelse af hyaluronsyre til behandling af betændelse i blæreslimhinden
AU5045690A (en) Composition and method for treating benign prostatic hypertrophy
DE69826684D1 (de) Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendungen
NO20000098L (no) Anvendelse av hyaluronidase ved fremstillingen av et medikament for behandling av inflammasjon
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
ITMI992107A0 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo
IT1318667B1 (it) Medicamento antinfiammatorio.
ES2192840T3 (es) Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal.
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
ES2090167T3 (es) Uso topico de glicosaminoglicanos en la prevencion y el tratamiento de enfermedades que afectan al tracto vaginal cervical.
DE69635806D1 (de) Diphosphonat derivate von therapeutisch wirksamen stoffen
NO20005223D0 (no) Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen
SE9603082L (sv) Användning av hyaluronidas
ES2161293T3 (es) Derivados de enol acilados como profarmacos de inhibidores de la elastasa.
DE68911049D1 (de) Therapeutische Verwendung des Isopropylesterderivates von Monosialogangliosiden bei Erkrankungen des Nervensystems, begleitet von Entzündungen.
AU7500200A (en) Combined therapies for atherosclerosis treatment

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application